Analysis of human monoclonal antibodies generated by dengue virus-specific memory B cells

Viral Immunology

Volumn 25, Issue 5, 2012, Pages 348-359

  Friberg, Heather ^a   Jaiswal, Smita ^a   West, Kim ^a   O'Ketch, Marvin ^a   Rothman, Alan L ^b   Mathew, Anuja ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; NONSTRUCTURAL PROTEIN 1; PREMEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CELL LYSATE; CONFORMATION; DENGUE; DENGUE VIRUS; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; MEMORY CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN BINDING; SEROTYPE;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIGENS, VIRAL; B-LYMPHOCYTES; DENGUE; DENGUE VIRUS; HUMANS; IMMUNOLOGIC MEMORY; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

DENGUE VIRUS;

EID: 84867213575     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2012.0010     Document Type: Article

References (41)

1. Beltramello M, Williams KL, Simmons CP, et al.: The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 2010;8: 271-283.
2. Cavacini L and Posner M: Native HIV type 1 virion surface structures: relationships between antibody binding and neutralization or lessons from the viral capture assay. AIDS Res Hum Retroviruses 2004;20:435-441.
3. Clements DE, Coller BA, Lieberman MM, et al.: Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys. Vaccine 2010;28:2705-2715.
4. Crill WD, Hughes HR, Delorey MJ, and Chang GJ: Humoral immune responses of dengue fever patients using epitopespecific serotype-2 virus-like particle antigens. PLoS One 2009;4:e4991.
5. Crill WD and Roehrig JT: Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 2001;75:7769-7773.
6. de Alwis R, Beltramello M, Messer WB, et al.: In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl Trop Dis 2010;5:e1188.
7. de Alwis R, Smith SA, Olivarez NP, et al.: Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc Natl Acad Sci USA 2012.
8. Dejnirattisai W, Jumnainsong A, Onsirisakul N, et al.: Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010;328:745-748.
9. Dowd KA and Pierson TC: Antibody-mediated neutralization of flaviviruses: a reductionist view. Virology 2011;411:306-315.
10. Falconar AK: Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins. Arch Virol 1999;144:2313-2330.
11. Falconar AK and Young PR: Production of dimer-specific and dengue virus group cross-reactive mouse monoclonal antibodies to the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol 1991;72(Pt 4):961-965.
12. Falconar AK, Young PR, and Miles MA: Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein. Arch Virol 1994;137:315-326.
13. Gagnon SJ, Zeng W, Kurane I, and Ennis FA: Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotypecross-reactive human CD4+ cytotoxic T-lymphocyte clones. J Virol 1996;70:141-147.
14. Guzman MG, Alvarez M, Rodriguez-Roche R, et al.: Neutralizing antibodies after infection with dengue 1 virus. Emerg Infect Dis 2007;13:282-286.
15. Henn AD, Rebhahn J, Brown MA, et al.: Modulation of single-cell IgG secretion frequency and rates in human memory B cells by CpG DNA, CD40L, IL-21, and cell division. J Immunol 2009;183:3177-3187.
16. Huggins J, Pellegrin T, Felgar RE, et al.: CpG DNA activation and plasma-cell differentiation of CD27-naive human B cells. Blood 2007;109:1611-1619.
17. Jackson SM, Wilson PC, James JA, and Capra JD: Human B cell subsets. Adv Immunol 2008;98:151-224.
18. Lai CY, Tsai WY, Lin SR, et al.: Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol 2008;82:6631-6643.
19. Mathew A, West K, Kalayanarooj S, et al.: B-cell responses during primary and secondary dengue virus infections in humans. J Infect Dis 2011;204:1514-1522.
20. Modis Y, Ogata S, Clements D, and Harrison SC: A ligandbinding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 2003;100:6986-6991.
21. Murphy BR and Whitehead SS: Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 2011;29:587-619.
22. O'Nions J and Allday MJ: Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein-Barr virus or T cell-derived mitogens. J Gen Virol 2004; 85:881-895.
23. Oliphant T, Nybakken GE, Engle M, et al.: Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol 2006;80: 12149-12159.
24. Perez-Andres M, Paiva B, Nieto WG, et al.: Human peripheral blood B-cell compartments: a crossroad in B-cell traffic. Cytometry B Clin Cytom 2010;78(Suppl 1):S47-S60.
25. Robinson JE, Holton D, Liu J, McMurdo H, Murciano A, and Gohd R: A novel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter wells coated with concanavalin A. J Immunol Methods 1990;132:63-71.
26. Rodenhuis-Zybert IA, van der Schaar HM, da Silva Voorham JM, et al.: Immature dengue virus: a veiled pathogen? PLoS Pathog 2010;6:e1000718.
27. Roehrig JT, Bolin RA, and Kelly RG: Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 1998;246:317-328.
28. Rothman AL: Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 2011;11:532-543.
29. Schieffelin JS, Costin JM, Nicholson CO, et al.: Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient. Virol J 2010;7:28.
30. Shrestha B, Brien JD, Sukupolvi-Petty S, et al.: The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog 2010;6:e1000823.
31. Simmons CP, Chau TN, Thuy TT, et al.: Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis 2007;196:416-424.
32. Smith SA, Zhou Y, Olivarez NP, Broadwater AH, de Silva AM, and Crowe JE Jr: Persistence of circulating B memory cell clones with potential for dengue virus disease enhancement for decades following infection. J Virol 2011; doi:10.1128/JVI.06335-11.
33. Sukupolvi-Petty S, Austin SK, Engle M, et al.: Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol 2010;84:9227-9239.
34. Sukupolvi-Petty S, Austin SK, Purtha WE, et al.: Type-and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol 2007;81:12816-12826.
35. Tangye SG, and Tarlinton DM: Memory B cells: effectors of long-lived immune responses. Eur J Immunol 2009;39:2065-2075.
36. Traggiai E, Becker S, Subbarao K, et al.: An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 2004;10:871-875.
37. Traggiai E, Chicha L, Mazzucchelli L, et al.: Development of a human adaptive immune system in cord blood celltransplanted mice. Science 2004;304:104-107.
38. Ungchusak K and Kunasol P: Dengue haemorrhagic fever in Thailand, 1987. Southeast Asian J Trop Med Public Health 1988;19:487-490.
39. Valdes K, Alvarez M, Pupo M, Vazquez S, Rodriguez R, and Guzman MG: Human Dengue antibodies against structural and nonstructural proteins. Clin Diagn Lab Immunol 2000;7: 856-857.
40. Wahala WM, Kraus AA, Haymore LB, Accavitti-Loper MA, and de Silva AM: Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology 2009;392:103-113.
41. Wrammert J, Smith K, Miller J, et al.: Rapid cloning of highaffinity human monoclonal antibodies against influenza virus. Nature 2008;453:667-671.